OSE Immunotherapeuti...
ENXTPA:OSE
3,29
€0,00 (0,00%)
3,29
€0,00 (0,00%)
End-of-day quote: 04/03/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

€1,48
Earnings Per Share
€3,82
Revenue Per Share
52,42%
Operating Margin %
€0,07 B
Market Cap
€0,04 B
Long-Term Debt
Earnings Per Share
€1,48
Revenue Per Share
€3,82
Operating Margin %
52,42%
Market Cap
€0,07 B
Long-Term Debt
€0,04 B

Financials

Year Year 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
EPS Earnings Per Share €1,48 €-1,18 €-0,96 €-0,93 €-1,06 €-0,31 €0,35 €-0,73 €1,65 €-0,59
Earnings Earnings €32,35M €-25,48M €-17,71M €-17,20M €-19,04M €-4,68M €5,17M €-10,55M €23,53M €-5,91M
RPS Revenue Per Share €3,82 €0,10 €0,99 €1,42 €0,58 €1,72 €1,66 €0,46 €0,03 €0,00
Revenue Revenue €83,44M €2,23M €18,30M €26,31M €10,43M €25,95M €24,46M €6,68M €0,38M €0,00M
OCF Operating Cash Flow €48,44M €-19,76M €-18,25M €-9,92M €-19,28M €9,14M €1,08M €-8,00M €0,68M €0,00M
FCF Free Cash Flow €48,36M €-30,70M €-18,53M €-10,39M €-19,49M €8,80M €0,48M €-8,35M €0,65M €-4,66M
OM Operating Margin 52,42% 0,00% -100,96% -63,20% -182,25% -5,67% 19,82% -188,94% -148,04% 0,00%
GM % Gross Margin % 100,00% 100,00% 100,00% 100,00% 100,00% 100,00% 100,00% 100,00% 100,00% 100,00%
FCFS Free Cash Flow Per Share €2,22 €-1,01 €-1,00 €-0,57 €-1,27 €0,59 €0,03 €-0,58 €0,05 €-0,49
LT Debt Long-Term Debt €35,66M €35,51M €37,23M €30,80M €16,55M €9,21M €3,83M €4,30M €1,20M €0,20M
Sha. Stocks 21,86M 21,59M 18,45M 18,49M 17,96M 15,11M 14,77M 14,45M 14,26M 10,02M
×